Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.

Millot F, Guilhot J, Baruchel A, Petit A, Bertrand Y, Mazingue F, Lutz P, Vérité C, Berthou C, Galambrun C, Sirvent N, Yakouben K, Schmitt C, Gandemer V, Reguerre Y, Couillault G, Mechinaud F, Cayuela JM.

Blood. 2014 Aug 28. pii: blood-2014-05-578567. [Epub ahead of print]

PMID:
25170123
[PubMed - as supplied by publisher]
2.

Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years.

de la Fuente J, Baruchel A, Biondi A, de Bont E, Dresse MF, Suttorp M, Millot F; International BFM Group (iBFM) Study Group Chronic Myeloid Leukaemia Committee.

Br J Haematol. 2014 Oct;167(1):33-47. doi: 10.1111/bjh.12977. Epub 2014 Jun 30.

PMID:
24976289
[PubMed - in process]
3.

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.

Domenech C, Suciu S, De Moerloose B, Mazingue F, Plat G, Ferster A, Uyttebroeck A, Sirvent N, Lutz P, Yakouben K, Munzer M, Röhrlich P, Plantaz D, Millot F, Philippet P, Dastugue N, Girard S, Cavé H, Benoit Y, Bertrandfor Y; Children's Leukemia Group (CLG) of European Organisation for Research and Treatment of Cancer (EORTC).

Haematologica. 2014 Jul;99(7):1220-7. doi: 10.3324/haematol.2014.103507. Epub 2014 Apr 11.

PMID:
24727815
[PubMed - in process]
Free PMC Article
4.

Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

Gathmann B, Mahlaoui N; CEREDIH, Gérard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW; Dutch WID, van Beem RT, Guzman D, Workman S, Soler-Palacín P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H, Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U, Meyts I, Kutukculer N, Wågström P, Galal NM, Roesler J, Farmaki E, Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S, Panahloo Z, Grimbacher B; European Society for Immunodeficiencies Registry Working Party.

J Allergy Clin Immunol. 2014 Jul;134(1):116-26. doi: 10.1016/j.jaci.2013.12.1077. Epub 2014 Feb 28.

PMID:
24582312
[PubMed - in process]
5.

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.

Pasmant E, Gilbert-Dussardier B, Petit A, de Laval B, Luscan A, Gruber A, Lapillonne H, Deswarte C, Goussard P, Laurendeau I, Uzan B, Pflumio F, Brizard F, Vabres P, Naguibvena I, Fasola S, Millot F, Porteu F, Vidaud D, Landman-Parker J, Ballerini P.

Oncogene. 2014 Jan 27. doi: 10.1038/onc.2013.587. [Epub ahead of print]

PMID:
24469042
[PubMed - as supplied by publisher]
6.

Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase.

Millot F, Claviez A, Leverger G, Corbaciglu S, Groll AH, Suttorp M.

Pediatr Blood Cancer. 2014 Feb;61(2):355-7. doi: 10.1002/pbc.24521. Epub 2013 Sep 17.

PMID:
24106110
[PubMed - indexed for MEDLINE]
7.

Primary lymphoma of bone infected with Staphylococcus aureus.

Paupière S, Millot F, Grados F, Fardellone P.

Joint Bone Spine. 2013 Dec;80(6):669-70. doi: 10.1016/j.jbspin.2013.03.016. Epub 2013 May 6. No abstract available.

PMID:
23660424
[PubMed - indexed for MEDLINE]
8.

Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases.

Chappé C, Riffaud L, Tréguier C, Carsin-Nicol B, Veillard D, Chiforeanu DC, Grill J, Frappaz D, André N, Millot F, Vinchon M, Sirvent N, Edan C.

Childs Nerv Syst. 2013 Apr;29(4):565-71. doi: 10.1007/s00381-012-2016-1. Epub 2013 Jan 10.

PMID:
23306961
[PubMed - indexed for MEDLINE]
9.

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group.

Clin Exp Immunol. 2013 Feb;171(2):186-94. doi: 10.1111/cei.12002.

PMID:
23286945
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Management of chronic myeloid leukemia in childhood.

Suttorp M, Eckardt L, Tauer JT, Millot F.

Curr Hematol Malig Rep. 2012 Jun;7(2):116-24. doi: 10.1007/s11899-012-0113-6. Review.

PMID:
22395816
[PubMed - indexed for MEDLINE]
11.

Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency.

Rivoisy C, Gérard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, Tron F, Masseau A, Bordigoni P, Alric L, Haroche J, Hoarau C, Bérézné A, Carmagnat M, Mouillot G, Oksenhendler E; DEFI study group.

J Clin Immunol. 2012 Feb;32(1):98-105. doi: 10.1007/s10875-011-9604-9. Epub 2011 Oct 15.

PMID:
22002594
[PubMed - indexed for MEDLINE]
12.

Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.

Millot F, Baruchel A, Guilhot J, Petit A, Leblanc T, Bertrand Y, Mazingue F, Lutz P, Vérité C, Berthou C, Galambrun C, Bernard F, Yacouben K, Bordigoni P, Edan C, Reguerre Y, Couillault G, Méchinaud F, Cayuela JM, Guilhot F.

J Clin Oncol. 2011 Jul 10;29(20):2827-32. doi: 10.1200/JCO.2010.32.7114. Epub 2011 Jun 13.

PMID:
21670449
[PubMed - indexed for MEDLINE]
Free Article
13.

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D; CEREDIH Network Investigators.

J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1. doi: 10.1016/j.jaci.2011.03.052. Epub 2011 Jun 12.

PMID:
21665257
[PubMed - indexed for MEDLINE]
14.

Quantitative and sensitive detection of rare mutations using droplet-based microfluidics.

Pekin D, Skhiri Y, Baret JC, Le Corre D, Mazutis L, Salem CB, Millot F, El Harrak A, Hutchison JB, Larson JW, Link DR, Laurent-Puig P, Griffiths AD, Taly V.

Lab Chip. 2011 Jul 7;11(13):2156-66. doi: 10.1039/c1lc20128j. Epub 2011 May 19.

PMID:
21594292
[PubMed - indexed for MEDLINE]
15.

Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.

Renard M, Suciu S, Bertrand Y, Uyttebroeck A, Ferster A, van der Werff Ten Bosch J, Mazingue F, Plouvier E, Robert A, Boutard P, Millot F, Munzer M, Mechinaud F, Lescoeur B, Baila L, Vandecruys E, Benoit Y, Philippet P; EORTC Children Leukaemia Group (CLG).

Pediatr Blood Cancer. 2011 Jul 15;57(1):119-25. doi: 10.1002/pbc.23083. Epub 2011 Mar 15.

PMID:
21412967
[PubMed - indexed for MEDLINE]
16.

Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort).

Millot F, Clavel G, Etchepare F, Gandjbakhch F, Grados F, Saraux A, Rat AC, Fautrel B, Bourgeois P, Fardellone P; Investigators of the French Early Arthritis Cohort ESPOIR.

J Rheumatol. 2011 Apr;38(4):613-20. doi: 10.3899/jrheum.100379. Epub 2011 Feb 1.

PMID:
21285167
[PubMed - indexed for MEDLINE]
17.

Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation.

Suttorp M, Millot F.

Hematology Am Soc Hematol Educ Program. 2010;2010:368-76. doi: 10.1182/asheducation-2010.1.368. Review.

PMID:
21239821
[PubMed - indexed for MEDLINE]
Free Article
18.

Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency.

Vince N, Boutboul D, Mouillot G, Just N, Peralta M, Casanova JL, Conley ME, Bories JC, Oksenhendler E, Malphettes M, Fieschi C; DEFI Study Group.

J Allergy Clin Immunol. 2011 Feb;127(2):538-541.e1-5. doi: 10.1016/j.jaci.2010.10.019. Epub 2010 Dec 14. No abstract available.

PMID:
21159371
[PubMed - indexed for MEDLINE]
19.

Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881.

Sirvent N, Suciu S, Rialland X, Millot F, Benoit Y, Plantaz D, Ferster A, Robert A, Lutz P, Nelken B, Plouvier E, Norton L, Bertrand Y, Otten J.

Eur J Cancer. 2011 Jan;47(2):239-47. doi: 10.1016/j.ejca.2010.10.019. Epub 2010 Nov 20.

PMID:
21095115
[PubMed - indexed for MEDLINE]
20.

Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.

Boileau J, Mouillot G, Gérard L, Carmagnat M, Rabian C, Oksenhendler E, Pasquali JL, Korganow AS; DEFI Study Group.

J Autoimmun. 2011 Feb;36(1):25-32. doi: 10.1016/j.jaut.2010.10.002. Epub 2010 Nov 13.

PMID:
21075598
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk